English |
Title | Percutaneous Cardiopulmonary Support in the Last Decade |
Subtitle | Original article |
Authors | Shigeyuki Sasaki*, Toshiteru Ishitani**, Satoshi Nanzaki**, Yuji Morimoto**, Osamu Kemmotsu**, Satoshi Gando**, Keishu Yasuda*** |
Authors(kana) | |
Organization | *Division of Medical Sciences, Health Science University of Hokkaido, Ishikari-Tobetsu, Japan, **Department of Anesthesiology and Critical Care Medicine, ***Department of Cardiovascular Surgery, Hokkaido University Graduate School of Medicine, Sapporo |
Journal | Circulation Control |
Volume | 22 |
Number | 2 |
Page | 125-131 |
Year/Month | 2001/ |
Article | Original article |
Publisher | Japan Society of Circulation Control |
Abstract | Percutaneous cardiopulmonary bypass support (PCPS) is a therapeutic option for patients with circulatory collapse. This study reviews clinical course and outcome of 19 patients treated with PCPS in the last decade at Hokkaido University Hospital. Patients included 13 males and 6 female with a mean age of 61.3 } 2.9 years. The underlying diseases were perioperative circulatory collapse or low cardiac output syndrome (LOS) in 15 (cardiotomy group; 9 undergoing surgery for ischemic heart disease (IHD) and 6 for valvular heart disease), pulmonary emboli in 3, and dilative cardiomyopathy (DCM) in 1 patient. Thirteen of 19 patients (68.4%) were weaned from PCPS and 10 (52.6%) patients achieved hospital discharge. Rates of weaning from PCPS and hospital discharge in each underlying disease were 11/15 and 8/15 in cardiotomy group, 2/3 and 2/3 in pulmonary embolism, 0/1 and 0/1 in DCM, respectively. In cardiotomy group, all survivors showed remarkable improvement of hemodynamic state within 48 hours after PCPS and were weaned from PCPS (mean PCPS running time: 23.4 } 4.7 hrs). In contrast, non-survivors (mean PCPS running time: 73.8 } 8.0 hrs) showed no improvement within 48 hours and developed major complications such as cerebral damage or multiple organ dysfunction syndrome. We conclude that there is few possibility of weaning from PCPS in cardiotomy patients who cannot show any signs of hemodynamic recovery within 48 hours after the institution of PCPS. The limited use of PCPS within 48 hours may be applicable for post-cardiotomy patients. For patients with massive pulmonary emboli, PCPS may be beneficial in resuscitating patients with circulatory collapse and may be used as a bridge to pulmonary embolectomy. |
Practice | Basic medicine |
Keywords | Circulatory support, Percutaneous cardiopulmonary bypass support (PCPS), Low cardiac output syndrome (LOS), Emergency extracorporeal circulation |